Antihemostatic Therapy and Endoscopic Biliary Sphincterotomy Induced Bleeding

The Effect of Antiaggregant, Anticoagulant and Nonsteroidal Antiinflammatory Therapy on Endoscopic Biliary Sphincterotomy Induced Bleeding

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01098617

Enrollment

350

Registered

2010-04-05

Start date

2010-04-30

Completion date

2010-12-31

Last updated

2010-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bleeding, Endoscopic Biliary Sphincterotomy

Keywords

endoscopic sphincterotomy, hemorrhage, nonsteroidal antiinflammatory agents, antiaggregants, anticoagulants, Endoscopic biliary sphincterotomy induced bleeding

Brief summary

The aim of the study is to observe the effects of antihemostatic therapy including nonsteroidal antiinflammatory, anticoagulant and antiaggregant therapy and other patient and procedure related factors on the risk of endoscopic biliary sphincterotomy induced bleeding.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

17 Years to No maximum

Healthy volunteers

Inclusion criteria

* Hospitalization * Endoscopic sphincterotomy * The patients whose warfarin treatment was stopped and INR was normalized prior to examination

Exclusion criteria

* The patients who had undergone endoscopic cholangiography with no sphincterotomy * Outpatient procedures

Design outcomes

Primary

Measure	Time frame
Bleeding induced by endoscopic biliary sphincterotomy	3 months

Countries

Turkey (Türkiye)

Contacts

Primary ContactIbrahim Koral Onal, MD

koralonal@yahoo.com903123061334

Outcome results